HomeInsightsStock Comparison

Fdc Ltd vs Zydus Lifesciences Ltd Stock Comparison

Fdc Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Jun 18, 2025

Key Highlights

  • The Latest Trading Price of FDC Ltd is ₹ 469.95 as of 18 Jun 11:50.
  • The P/E Ratio of FDC Ltd changed from 14 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 10.05% over 5 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 2.37% over 5 years.
  • The Market Cap of FDC Ltd changed from ₹ 3350 crore on March 2020 to ₹ 6912 crore on March 2024 . This represents a CAGR of 15.59% over 5 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 101151 crore on March 2024 . This represents a CAGR of 29.90% over 5 years.
  • The revenue of FDC Ltd for the Mar '25 is ₹ 507.97 crore as compare to the Dec '24 revenue of ₹ 482.94 crore. This represent the growth of 5.18% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of FDC Ltd for the Mar '25 is ₹ 70.06 crore as compare to the Dec '24 ebitda of ₹ 65.48 crore. This represent the growth of 6.99% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of FDC Ltd changed from ₹ 109.81 crore to ₹ 38.67 crore over 8 quarters. This represents a CAGR of -40.66% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 5.97% .
  • The Dividend Payout of FDC Ltd changed from 5.54 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 8.77 % on March 2024 . This represents a CAGR of -19.14% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About FDC Ltd

  • FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
  • The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
  • It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
  • It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

FDC Ltd News Hub

News

Volumes jump at FDC Ltd counter

Bajaj Finance Ltd, P I Industries Ltd, Anand Rathi Wealth Ltd, Cipla Ltd are among the oth...

Read more

16 Jun 2025 11:00

News

FDC to conduct board meeting

FDC will hold a meeting of the Board of Directors of the Company on 28 May 2025. Powered b...

Read more

23 May 2025 17:29

News

FDC to declare Quarterly Results

FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025. Powe...

Read more

08 Feb 2025 11:03

News

FDC gets USFDA nod for anti-bacterial drug

The announcement was made at the fag end of market hours yesterday. Cefixime is used to tr...

Read more

19 Dec 2024 10:47

News

Board of FDC recommends first interim dividend

FDC announced that the Board of Directors of the Company at its meeting held on 6 November...

Read more

07 Nov 2024 15:15

News

FDC schedules board meeting

FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powere...

Read more

29 Oct 2024 15:20

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences appoints Managing Director

Zydus Lifesciences has approved the appointment of s. Swati Dalal as the Additional Direct...

Read more

16 Jun 2025 14:16

News

Zydus Life subsidiary ZHL appoints Swati Dalal as MD

The appointment was approved by the nomination and remuneration committee (NRC). Swati Dal...

Read more

16 Jun 2025 14:42

News

Zydus Life receives USFDA EIR for Gujarat facility

The inspection was conducted by the USFDA from March 10 to March 14, 2025. Following the r...

Read more

12 Jun 2025 09:55

News

Zydus' Ankleshwar API unit clears USFDA inspection

Zydus Lifesciences has received the Establishment Inspection Report (EIR) report from the ...

Read more

12 Jun 2025 10:41

News

Zydus Lifesciences Ltd spurts 0.24%, up for fifth straight session

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at R...

Read more

10 Jun 2025 13:00

News

Zydus receives EIR for the API manufacturing facility at Dabhasa

  Zydus Lifesciences has received the EIR report from the USFDA for the inspection conduct...

Read more

10 Jun 2025 14:11

SWOT Analysis Of FDC Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for FDC Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of FDC Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, FDC Ltd or Zydus Lifesciences Ltd?

Market cap of FDC Ltd is 7,703 Cr while Market cap of Zydus Lifesciences Ltd is 96,487 Cr

What are the key factors driving the stock performance of FDC Ltd and Zydus Lifesciences Ltd?

The stock performance of FDC Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Zydus Lifesciences Ltd?

As of June 18, 2025, the FDC Ltd stock price is INR ₹473.15. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹958.9.

How do dividend payouts of FDC Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of FDC Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions